Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01743560
Brief Title: An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis (4EVERUK)

First Submitted : October 24, 2012
First Submitted that Met QC Criteria : December 4, 2012
First Posted : December 6, 2012 (Estimate)

Results First Submitted : August 14, 2017
Results First Submitted that Met QC Criteria : December 31, 2018
Results First Posted : April 1, 2019

Last Update Submitted that Met QC Criteria : July 16, 2019
Last Update Posted : July 18, 2019